Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
In: GlobeNewswire, 2024-05-01
Zeitungsartikel
Zugriff:
HAMILTON, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors, today announced [...]
Titel: |
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
|
---|---|
Zeitschrift: | GlobeNewswire, 2024-05-01 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|